Genedata Expressionist 18.5 Introduces Automated Characterization Workflows for Novel Therapeutics
AIT365 News Desk -
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the latest release of Genedata Expressionist®18.5, a platform for streamlining and automating characterization and quality monitoring of biotherapeutics using mass spectrometry (MS). This release provides an innovative new workflow for oligonucleotide characterization and additional functionalities for high-throughput...
MiLaboratories, a leader in computational biology innovation, is thrilled to announce the successful close of its Series A funding round, led by Madrid-based Kfund, with additional backing from Speedinvest and other prominent international investors. This funding milestone comes alongside the launch of its cutting-edge Platforma.bio Software Development Kit (SDK),...
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and BioNex Solutions, Inc., provider of advanced laboratory automation systems, announced a collaboration designed to deliver an enhanced experience for customers using the Hive Laboratory Automation platform.
BioNex developed the Hive Laboratory Automation platform, which features an innovative vertical...
Storj announces the acquisition of PetaGene, creator of cunoFS, to build on growth propelled by Storj's recent acquisition of distributed GPU provider, Valdi. With today's news, Storj now delivers distributed cloud object storage, distributed on-demand GPU compute, and distributed file storage mount. Together, these capabilities provide seamless access to the distributed cloud for...
ModuleMD announced the launch of JOSH, Revolutionizing Clinical Workflow with AI-Powered Notes for Clinical Teams
AIT365 News Desk -
ModuleMD, a leading innovator in healthcare technology for over 24 years, proudly announces the launch of JOSH, an AI-powered dictation tool designed to revolutionize clinical workflows. ModuleMD has been at the forefront of healthcare innovation, offering specialty-focused Electronic Health Record (EHR) and practice management solutions across Allergy, ENT, and Pulmonology practices....
PictorLabs, a leader in AI-powered virtual staining technology, and Hamamatsu Photonics, a renowned provider of whole slide imaging systems, are excited to announce a strategic partnership to develop cutting-edge applications to advance virtual staining in routine laboratory practices.
Innovations with AI and advanced imaging
PictorLabs, a rapidly growing startup spun off...
IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
IQVIA AI Assistant is a user-friendly,...
BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.
The collaboration aims to leverage BioAI's PredictX platform to develop AI-based models using Arbele's...
Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing cardiovascular disease in general hospitals and clinics.
The financing round was led by Korea Development Bank (KDB), with participation from Woori Venture Partners,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration with Takeda that takes a data-first approach to research and development, with the aim of enhancing Takeda’s oncology research and development efforts.
After an initial collaboration...